Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 2
1989 2
1994 1
1995 1
1997 1
1998 2
1999 2
2000 5
2001 1
2002 6
2003 9
2004 6
2005 5
2006 11
2007 11
2008 13
2009 8
2010 16
2011 20
2012 17
2013 13
2014 16
2015 20
2016 19
2017 22
2018 19
2019 31
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

266 results
Results by year
Filters applied: . Clear all
Page 1
[Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].
Zhang LL, Li YF, Zhang C, Wu XF, Ma Y, Li L. Zhang LL, et al. Zhonghua Gan Zang Bing Za Zhi. 2019 Oct 20;27(10):788-792. doi: 10.3760/cma.j.issn.1007-3418.2019.10.010. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31734994 Chinese.
Objective: To investigate whether type 2 diabetes mellitus increases the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma, and …
Objective: To investigate whether type 2 diabetes mellitus increases the risk of hepatitis B-relat …
Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review.
Tan Y, Wei S, Zhang W, Yang J, Yang J, Yan L. Tan Y, et al. Cancer Manag Res. 2019 Jan 14;11:705-713. doi: 10.2147/CMAR.S188238. eCollection 2019. Cancer Manag Res. 2019. PMID: 30679924 Free PMC article. Review.
BACKGROUND: Type 2 diabetes mellitus has been proved to be a risk factor of hepatocellular carcinoma, but how diabetes affects incidence of hepatocellular carcinoma among patients with chronic hepatitis B virus infection remains co …
BACKGROUND: Type 2 diabetes mellitus has been proved to be a risk factor of hepatocellular carcinoma, but how …
Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta-analysis.
Shen Y, Zhang S, Wang X, Wang Y, Zhang J, Qin G, Li W, Ding K, Zhang L, Liang F. Shen Y, et al. Liver Int. 2017 Oct;37(10):1451-1460. doi: 10.1111/liv.13275. Epub 2017 Aug 25. Liver Int. 2017. PMID: 27753241
BACKGROUND: Because whether hepatitis B virus infection increases the risk of type 2 diabetes mellitus has been a controversial topic, pair-wise and network meta-analyses of published literature were carried out to accurately evaluate the …
BACKGROUND: Because whether hepatitis B virus infection increases the risk of type 2 diabetes mellitus
Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes.
Lu J, Hou X, Tu H, Tang Z, Xiang Y, Bao Y, Gu J, Jia W. Lu J, et al. J Diabetes Investig. 2017 Jul;8(4):619-625. doi: 10.1111/jdi.12609. Epub 2017 Mar 13. J Diabetes Investig. 2017. PMID: 27930871 Free PMC article.
AIMS/INTRODUCTION: It has not been reported whether chronic hepatitis B virus infection (CHB) is associated with a specific type of diabetes. ...Patients were grouped as hepatitis B virus-negative and CHB status. RESULTS: Patients with …
AIMS/INTRODUCTION: It has not been reported whether chronic hepatitis B virus infection (CHB) is associated with a specific …
Association of fasting serum glucose level and type 2 diabetes with hepatocellular carcinoma in men with chronic hepatitis B infection: A large cohort study.
Kim K, Choi S, Park SM. Kim K, et al. Eur J Cancer. 2018 Oct;102:103-113. doi: 10.1016/j.ejca.2018.07.008. Epub 2018 Sep 4. Eur J Cancer. 2018. PMID: 30189372
BACKGROUND: It is unclear whether elevated fasting serum glucose level and type 2 diabetes (T2DM) are associated with an increased risk of hepatocellular carcinoma (HCC), irrespective of obesity in patients with chronic hepatitis B. ...Glycaemic …
BACKGROUND: It is unclear whether elevated fasting serum glucose level and type 2 diabetes (T2DM) are associated with a …
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years.
Hyer RN, Janssen RS. Hyer RN, et al. Vaccine. 2019 Sep 16;37(39):5854-5861. doi: 10.1016/j.vaccine.2019.08.005. Epub 2019 Aug 17. Vaccine. 2019. PMID: 31431412 Free article.
Commonly used 3-dose HBV vaccines have reduced immunogenicity in older individuals and in those with diabetes mellitus. METHODS: In this post hoc analysis of a phase 3 clinical trial, participants with type 2 diabetes mellitus aged 60-70 …
Commonly used 3-dose HBV vaccines have reduced immunogenicity in older individuals and in those with diabetes mellitus. METHOD …
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.
Fabiani S, Fallahi P, Ferrari SM, Miccoli M, Antonelli A. Fabiani S, et al. Rev Endocr Metab Disord. 2018 Dec;19(4):405-420. doi: 10.1007/s11154-017-9440-1. Rev Endocr Metab Disord. 2018. PMID: 29322398
Type 2 diabetes mellitus (T2DM) is an endocrine disorder encompassing multifactorial mechanisms, and chronic hepatitis C virus infection (CHC) is a multifaceted disorder, associated with extrahepatic manifestations, including endocrinological di
Type 2 diabetes mellitus (T2DM) is an endocrine disorder encompassing multifactorial mechanisms, and chronic
Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals.
Villar LM, Geloneze B, Vasques ACJ, Pires MLE, Miguel JC, da Silva EF, Marques VA, Scalioni LP, Lampe E. Villar LM, et al. PLoS One. 2019 Feb 28;14(2):e0211193. doi: 10.1371/journal.pone.0211193. eCollection 2019. PLoS One. 2019. PMID: 30817756 Free PMC article.
Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, like hepatitis B or C virus. ...Thirteen patients (2.42%) had anti-HCV and 7 of them were HCV RNA+. In the subgroup, ant
Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, l
Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.
Van Der Meeren O, Peterson JT, Dionne M, Beasley R, Ebeling PR, Ferguson M, Nissen MD, Rheault P, Simpson RW, De Ridder M, Crasta PD, Miller JM, Trofa AF. Van Der Meeren O, et al. Hum Vaccin Immunother. 2016 Aug 2;12(8):2197-2203. doi: 10.1080/21645515.2016.1164362. Epub 2016 Apr 28. Hum Vaccin Immunother. 2016. PMID: 27123743 Free PMC article. Clinical Trial.
Objective: Patients with diabetes mellitus are at increased risk for hepatitis B virus (HBV) infection and its complications. ...We assessed the safety and immunogenicity of recombinant hepatitis B vaccine in subjects with and without …
Objective: Patients with diabetes mellitus are at increased risk for hepatitis B virus (HBV) infection and its c …
Dual Infection with Hepatitis B Virus and Hepatitis C Virus Correlated with Type 2 Diabetes Mellitus.
Lin PY, Chen SC, Lo TC, Kuo HW. Lin PY, et al. Exp Clin Endocrinol Diabetes. 2020 Jan;128(1):38-42. doi: 10.1055/a-0794-6135. Epub 2019 Jan 17. Exp Clin Endocrinol Diabetes. 2020. PMID: 30654388
BACKGROUND: Conflicting data exist regarding the relationship between dual infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with type 2 diabetes mellitus (T2DM). ...Blood samples were collected and tested for hep
BACKGROUND: Conflicting data exist regarding the relationship between dual infection of hepatitis B virus (HBV) and hepatit
266 results
Jump to page
Feedback